Viewing Study NCT06531200



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06531200
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-28

Brief Title: Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep Learning
Sponsor: None
Organization: None

Study Overview

Official Title: Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia in Assessment With the Technology of Deep Learning
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to develop and validate a fully automated imaging deep learning platform for the evaluation of sarcopenia in liver cirrhosis Based on this model a new prognostic model for liver cirrhosis incorporating imaging biomarkers such as sarcopenia will be constructed and its predictive performance will be validated
Detailed Description: The goal of this observational study is to collect clinical and abdominal imaging data of patients with liver cirrhosis The collected imaging data will be used as a model development set to develop test and internally validate a fully automated imaging deep learning platform for the evaluation of sarcopenia in liver cirrhosis Subsequently relevant data from patients with liver cirrhosis at other centers will be collected and used as an external validation dataset The model will be externally validated by abdominal radiology experts Furthermore we will include sociodemographic information clinical data imaging data and clinical outcomes of the aforementioned liver cirrhosis patients to predict the prognosis of these patients using the established model This model will be used to construct a new prognostic model for liver cirrhosis incorporating imaging biomarkers such as sarcopenia and its predictive performance will be validated

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None